You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -1,602.9% | -833.3% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -12.0 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 165.6 | 78.1 |
| Price / Book value | 5.8 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 7.9% | -46.6% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 4.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2015-04-30 | n/a | -3.87 | -8.12p | -11.6 | 0.0 | n/a | n/a | 0.0% |
| 2016-04-30 | 0.36 | -5.43 | -8.69p | -7.8 | 0.0 | n/a | n/a | 0.0% |
| 2017-04-30 | 0.50 | -7.41 | -8.95p | -5.8 | 0.0 | n/a | n/a | 0.0% |
| 2018-04-30 | 0.63 | -8.93 | -7.91p | -6.0 | 0.0 | n/a | n/a | 0.0% |
| 2019-04-30 | 0.68 | -10.87 | -6.56p | -11.6 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-04-30 | 1.44 | -12.02 | -6.35p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2021-04-30 | 3.37 | -10.29 | -5.29p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| Angle upbeat on patent grant for prostate cancer blood assessment Sharecast News | 04 Oct |
|---|---|
| Angle initiates main phase of ovarian cancer clinical study Sharecast News | 29 Aug |
| Angle looks to strengthen balance sheet and extend runway via placement Sharecast News | 25 Jun |
| Notice of AGM | 08-Oct-19 07:05 |
|---|---|
| Holding(s) in Company | 04-Oct-19 17:54 |
| Research with Parsortix in prostate cancer | 10-Sep-19 07:04 |
| Initiation of Ovarian Cancer Study | 29-Aug-19 07:02 |
| Prelim Results for the year ended 30 April 2019 | 31-Jul-19 07:05 |